Safety Study of Autologous Stem Cell in Liver Cirrhosis

This study has been terminated.

( Other authors showed the same metabolic effect may be obtained when BMMC are delivered peripherally, with lower risk and cost than through hepatic artery. )

Study NCT00382278 Information provided by Federal University of Rio de Janeiro

First Received: September 28, 2006 Last Updated: April 2, 2008 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been terminated.
Study Completion Date:	February 2008
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)